Inogen Inc
INGNNasdaqCIK 1294133HealthcareFiscal year ends Dec 31
Reports and events: 217 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3016:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001294133-26-000037 |
| 2026-08-0716:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001294133-26-000034 |
| 2026-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001294133-26-000032 |
| 2026-07-0116:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001294133-26-000025 |
| 2026-06-1116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001294133-26-000021 |
| 2026-05-0816:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001294133-26-000016 |
| 2026-05-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001294133-26-000014 |
| 2026-04-2816:09 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001294133-26-000009 |
| 2026-04-0616:02 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-143703 |
| 2026-03-3017:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-131855 |
| 2026-02-2716:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-082630 |
| 2026-02-2416:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-066968 |
| 2026-01-1208:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009878 |
| 2025-11-0616:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269484 |
| 2025-11-0507:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265750 |
| 2025-08-0816:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105835 |
| 2025-08-0716:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105080 |
| 2025-07-2916:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-099624 |
| 2025-05-1916:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-074437 |
| 2025-05-0816:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066966 |
| 2025-05-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065644 |
| 2025-03-2708:01 ET | DEF 14A | Proxy statementPeriod 2025-03-27 | 0000950170-25-045737 |
| 2025-02-2816:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029993 |
| 2025-02-2516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026636 |
| 2025-02-0316:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-012334 |
| 2025-01-2706:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-008986 |
| 2025-01-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-004824 |
| 2024-12-3008:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-140955 |
| 2024-11-0816:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124115 |
| 2024-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123329 |
| 2024-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092743 |
| 2024-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091800 |
| 2024-07-3117:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-088682 |
| 2024-07-0316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-081526 |
| 2024-06-0717:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070900 |
| 2024-05-1517:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-060589 |
| 2024-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055627 |
| 2024-05-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054483 |
| 2024-04-1816:05 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0000950170-24-045541 |
| 2024-04-1516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-044416 |
| 2024-03-0116:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023820 |
| 2024-02-2716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021113 |
| 2024-01-2416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-006969 |
| 2024-01-0509:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-002303 |
| 2023-11-2716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-066108 |
| 2023-11-1308:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-062492 |
| 2023-11-0913:33 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061784 |
| 2023-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060245 |
| 2023-09-1808:32 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-048471 |
| 2023-09-0708:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-046888 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.